Organization
UCB Pharma, Colombes, France
3 abstracts
Abstract
ARE RHEUMATOID ARTHRITIS PATIENTS WILLING TO USE AN E-HEALTH INTERACTIVE SELF-ASSESSMENT WEBSITE? ANALYSES OF 159 PATIENTS FROM A RANDOMISED CONTROLLED TRIAL OVER 12 MONTHS Org: CarNET Study Group, Paris, UCB Pharma, Colombes, France,
Abstract
BIMEKIZUMAB EFFICACY THROUGH 3 YEARS IN PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS: LONG-TERM POOLED ANALYSIS FROM BE BRIGHTOrg: UCB Pharma, Morrisville, North Carolina, United States of America, UCB Pharma, Monheim, Germany, UCB Pharma, Colombes, France,
Abstract
BIMEKIZUMAB MAINTAINED EFFICACY RESPONSES THROUGH 52 WEEKS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM TWO PHASE 3 STUDIESOrg: Royal National Hospital of Rheumatic Diseases, Bath, United Kingdom, Centre for Therapeutic Innovation, University of Bath, Department of Life Sciences, Bath, United Kingdom, University of Occupational and Environmental Health, The First Department of Internal Medicine, Kitakyushu, Fukuoka, Japan, Institute and Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany, UCB Pharma, Slough, United Kingdom,